1. Pembrolizumab
    , 2022, Reactions Weekly CrossRef
  2. Immunotherapy-induced thyroid dysfunction: an updated review
    Bahaaeldin Baraka et al, 2023, Egypt J Intern Med CrossRef
  3. null
    Walter Glannon, 2023 CrossRef